Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 19(1): e0297626, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38271388

RESUMO

INTRODUCTION: Antimicrobial resistance (AMR) is a global threat that necessitates coordinated strategies to improve antibiotic prescribing and reduce AMR. A key activity is ascertaining current prescribing patterns in hospitals to identify targets for quality improvement programmes. METHODS: The World Health Organisation point prevalence survey methodology was used to assess antibiotic prescribing in the Cape Coast Teaching Hospital. All core variables identified by the methodology were recorded. RESULTS: A total of 78.8% (82/104) patients were prescribed at least one antibiotic, with the majority from adult surgical wards (52.14%). Significantly longer hospital stays were associated with patients who underwent surgery (p = 0.0423). "Access" antibiotics dominated total prescriptions (63.8%, 132/207) with ceftriaxone, cefuroxime, and ciprofloxacin being the most prescribed "Watch" antibiotics. The most common indications were for medical prophylaxis (59.8%, 49/82) and surgical prophylaxis (46.3%, 38/82). Over one-third of surgical prophylaxis (34.2%, 13/38) indications extended beyond one day. There was moderate documentation of reasons for antibiotic treatment in patient notes (65.9%, 54/82), and targeted therapy after samples were taken for antimicrobial susceptibility testing (41.7%, 10/24). Guideline compliance was low (25%) where available. CONCLUSIONS: There was high use of antibiotics within the hospital which needs addressing. Identified quality targets include developing surgical prophylaxis guidelines, reviewing "Watch" antibiotic prescribing, and assessing antibiotic durations for patients on two or more antibiotics. Organizational-level deficiencies were also identified that need addressing to help instigate ASPs. These can be addressed by developing local prescribing protocols and antibiotic stewardship policies in this hospital and wider in Ghana and across Africa.


Assuntos
Antibacterianos , Gestão de Antimicrobianos , Adulto , Humanos , Antibacterianos/uso terapêutico , Gana/epidemiologia , Prevalência , Inquéritos e Questionários , Hospitais de Ensino , Prescrições de Medicamentos
2.
J Microbiol Methods ; 190: 106322, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34506810

RESUMO

Group B Streptococcus (GBS) is a leading cause of neonatal meningitis, pneumonia, and sepsis. The biggest contributing factor of neonatal infections is due to vertical transmission from maternal colonisation of GBS in the genitourinary tract. Multiple serotype colonisation is often not investigated in epidemiological studies, but it is an important consideration for serotype-based vaccine development and implementation to ensure less abundant serotypes are not under-represented. In this study, we show that RAPD PCR is a quick tool useful in screening the presence of genetically different strains using multiple colony picks from a single patient swab. We observed a maximum of five different GBS strains colonising a single patient at a specific time.


Assuntos
Programas de Rastreamento/métodos , Reação em Cadeia da Polimerase/métodos , Técnica de Amplificação ao Acaso de DNA Polimórfico/métodos , Streptococcus agalactiae/genética , Streptococcus agalactiae/isolamento & purificação , DNA Bacteriano , Feminino , Humanos , Lactente , Leite Humano/microbiologia , Nasofaringe/microbiologia , Polimorfismo de Nucleotídeo Único , Reto/microbiologia , Sorogrupo , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/microbiologia , Vagina/microbiologia , Sequenciamento Completo do Genoma
3.
Clin Microbiol Infect ; 27(11): 1697.e1-1697.e5, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34186210

RESUMO

OBJECTIVES: To determine the presence and genotypic macrolide susceptibility of Mycoplasma amphoriforme, and the presence of Ureaplasma spp. and Mycoplasma fermentans among clinical samples from England previously investigated for Mycoplasma pneumoniae. METHODS: Quantitative and conventional PCR methods were used to retrospectively screen a collection of 160 clinical samples previously submitted to Public Health England (PHE) for the detection of M. pneumoniae between October 2016 and December 2017. Samples which were positive for M. amphoriforme DNA were further investigated for mutations associated with genotypic macrolide resistance by sequencing domain V of the 23s rRNA. RESULTS: M. amphoriforme was detected in 10/160 samples (6.3%), Ureaplasma parvum was detected in 4/160 samples (2.5%), and M. fermentans was not detected in any samples (0/160). Of the nine individuals (two samples were from the same patient) in which M. amphoriforme was detected, eight were male (age range 10-60 years) and one was female (age range 30-40 years). One individual with cystic fibrosis was positive for both M. amphoriforme and U. parvum. All M. amphoriforme DNA was genotypically susceptible to macrolides. CONCLUSIONS: Mycoplasma amphoriforme was found in clinical samples, including lower respiratory tract samples of patients with pneumonia. In the absence of other respiratory pathogens, these data suggest a potential role for this organism in human disease, with no evidence of acquired macrolide resistance. Ureaplasma parvum was detected in cerebrospinal fluid and respiratory tract samples. These data suggest that there is a need to consider these atypical respiratory pathogens in future diagnostic investigations.


Assuntos
Infecções por Mycoplasma , Mycoplasma fermentans , Mycoplasma/isolamento & purificação , Ureaplasma/isolamento & purificação , Adolescente , Adulto , Antibacterianos/farmacologia , Criança , Farmacorresistência Bacteriana/genética , Feminino , Humanos , Macrolídeos/farmacologia , Masculino , Pessoa de Meia-Idade , Mycoplasma/efeitos dos fármacos , Mycoplasma/genética , Infecções por Mycoplasma/epidemiologia , Mycoplasma fermentans/efeitos dos fármacos , Mycoplasma fermentans/genética , Mycoplasma fermentans/isolamento & purificação , Estudos Retrospectivos , Ureaplasma/efeitos dos fármacos , Ureaplasma/genética , Adulto Jovem
4.
Pediatrics ; 138(2)2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27418415

RESUMO

Isolation of Ureaplasma spp. from preterm neonates and the association with development of bronchopulmonary dysplasia has been previously investigated. However, few studies have contrasted the nature of infection in twins. In this article, we report that dizygotic twins (1 girl, 1 boy) born at 24 weeks gestation both yielded culturable Ureaplasma from endotracheal secretions. The samples were part of a serial blind collection cohort of ventilated premature neonates, and analysis of repeat cultures showed stable, separate infections over a period of 17 and 21 days, respectively. Immunoblot and probe-specific quantitative polymerase chain reaction analysis determined that Twin 1 was solely infected with Ureaplasma parvum (specifically, serovar 6 by gene sequencing), whereas Twin 2 was solely infected with Ureaplasma urealyticum (specifically, genotype A- serovars 2, 5, and 8 by gene sequencing). Immunoblot analysis found that the major surface antigen (multiple-banded antigen) altered relative mass for both strains during the course of infection. Quantitative polymerase chain reaction analysis of extracted endotracheal aspirates confirmed no evidence of mixed infection for either twin. Failure of sentinel ventilated preterm infants on the same ward to acquire Ureaplasma infection after the first week of birth suggests no cot-to-cot transfer of Ureaplasma infection occurred. This study demonstrated not only a contrasting clinical outcome for a set of twins infected with 2 separate species of Ureaplasma, but also the first real-time demonstration of multiple-banded antigen alteration and evolution of Ureaplasma over the course of a clinical infection.


Assuntos
Secreções Corporais/microbiologia , Doenças em Gêmeos/microbiologia , Traqueia/microbiologia , Infecções por Ureaplasma/microbiologia , Ureaplasma/isolamento & purificação , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Ureaplasma/classificação
5.
J Zoo Wildl Med ; 35(1): 25-33, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15193070

RESUMO

During the months of April to August in 1999 and 2002, oral swabs were collected from 146 tortoises (Testudo sp.) in private collections in the United Kingdom and tested by polymerase chain reaction (PCR) for the presence of Mycoplasma agassizii and Chelonian herpesvirus (ChHV). The presence of M. agassizii was confirmed by restriction digestion of the PCR product. A 307-bp fragment of the ChHV UL5 homologue gene was sequenced and found to show most similarity to equine herpesvirus type 1. A prevalence of 15.8 and 8.2% was found for M. agassizii and ChHV, respectively. Comparison of the carriage of both M. agassizii and ChHV in different species of tortoises correlated the presence of M. agassizii with Testudo horsfieldii and ChHV with Testudo marginata and Testudo graeca iberia. An association of ChHV with stomatitis was also found. Mixed infections with both agents were detected. The findings further demonstrate this pathogen-tortoise association and the cross transmission of these infections if different tortoise species are housed together.


Assuntos
Infecções por Herpesviridae/veterinária , Herpesviridae/isolamento & purificação , Infecções por Mycoplasma/veterinária , Mycoplasma/isolamento & purificação , Tartarugas/microbiologia , Animais , DNA Bacteriano/análise , DNA Viral/análise , Reservatórios de Doenças/veterinária , Feminino , Infecções por Herpesviridae/epidemiologia , Infecções por Herpesviridae/transmissão , Masculino , Infecções por Mycoplasma/epidemiologia , Infecções por Mycoplasma/transmissão , Prevalência , Estomatite/veterinária , Estomatite/virologia , Tartarugas/virologia , Reino Unido/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA